Ascletis Pharma Inc. (HKG:1672)
Hong Kong · Delayed Price · Currency is HKD 10.25
+0.43 (4.33%)
Aug 20, 2026, 4:09 PM HKT
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 10.83 billion as of August 20, 2026. Its market cap has decreased by -27.60% in one year.
Market Cap
10.83B
Enterprise Value
8.71B
Revenue
2.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.25
ChartMarket Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 10.83B, a decrease of -30.99%. That is a compound annual growth rate of -4.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 10.83B | -3.68% |
| Dec 31, 2025 | 11.24B | 287.10% |
| Dec 31, 2024 | 2.90B | 90.74% |
| Dec 29, 2023 | 1.52B | -70.46% |
| Dec 30, 2022 | 5.15B | 44.13% |
| Dec 31, 2021 | 3.58B | 13.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Metis TechBio | 14.19B |
| HBM Holdings | 13.03B |
| Ascentage Pharma Group International | 12.87B |
| GenFleet Therapeutics (Shanghai) | 11.56B |
| TenNor Therapeutics (Suzhou) | 10.73B |
| Shaanxi Micot Pharmaceutical Technology | 10.53B |
| Everest Medicines | 10.29B |
| Suzhou Ribo Life Science | 8.84B |